# A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C

> **NCT00800748** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 372 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00800748
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-01
- **Primary completion:** 2009-01-09
- **Final completion:** 2009-01-09
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800748, "A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00800748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*